Skip to main content
logo
GB Sciences, Inc. (GBLX)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
Sep 24, 2026, 9:30 AM EST

GB Sciences Financials Overview

Millions USD. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec '24 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20
Revenue
0.1-----
Revenue Growth
------
Gross Profit
0.1-----
Operating Income
-0.85-1.42-1.67-1.87-2-5.74
Net Income
-1.06-1.64-4.13-0.53-3.73-12.37
Earnings Per Share
-0.00-0.00-0.01-0.00-0.01-0.05
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec '24 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20
Cash & Investments
00.010.110.230.790
Total Debt
1.991.761.41.383.975.79
Net Cash (Debt)
-1.99-1.75-1.29-1.15-3.18-5.79
Net Cash Growth
------
Net Cash Per Share
-0.00-0.00-0.00-0.00-0.01-0.02

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec '24 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20
Operating Cash Flow
-0.51-0.98-1.53-1.87-2.19-4.48
Capital Expenditures
------
Free Cash Flow
-0.51-0.98-1.53-1.87-2.19-4.48
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec '24 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20
Gross Margin
100.00%-----
Operating Margin
-872.53%-----
Profit Margin
-1085.52%-----
FCF Margin
-520.84%-----

Valuation
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '26 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20
PS Ratio
1.09-----